• Radiation Oncology Journal
• /
• 제32권4호
• /
• pp.238-246
• /
• 2014

Purpose: To evaluate the clinical outcome of high-dose-rate (HDR) interstitial brachytherapy (IBT) in patients with oral cavity cancer. Materials and Methods: Sixteen patients with oral cavity cancer treated with HDR remote-control afterloading brachytherapy using $^{192}Ir$ between 2001 and 2013 were analyzed retrospectively. Brachytherapy was administered in 11 patients as the primary treatment and in five patients as salvage treatment for recurrence after the initial surgery. In 12 patients, external beam radiotherapy (50-55 Gy/25 fractions) was combined with IBT of 21 Gy/7 fractions. In addition, IBT was administered as the sole treatment in three patients with a total dose of 50 Gy/10 fractions and as postoperative adjuvant treatment in one patient with a total of 35 Gy/7 fractions. Results: The 5-year overall survival of the entire group was 70%. The actuarial local control rate after 3 years was 84%. All five recurrent cases after initial surgery were successfully salvaged using IBT ${\pm}$ external beam radiotherapy. Two patients developed local recurrence at 3 and 5 months, respectively, after IBT. The acute complications were acceptable (${\leq}grade$ 2). Three patients developed major late complications, such as radio-osteonecrosis, in which one patient was treated by conservative therapy and two required surgical intervention. Conclusion: HDR IBT for oral cavity cancer was effective and acceptable in diverse clinical settings, such as in the cases of primary or salvage treatment.

• Radiation Oncology Journal
• /
• 제35권1호
• /
• pp.25-31
• /
• 2017

Purpose: The purpose of this study was to describe treatment patterns of radiotherapy (RT) for prostate cancer in Korea. Materials and Methods: A questionnaire about radiation treatment technique and principles in 2013 was sent to 83 radiation oncologists and data from 57 hospitals were collected analyzed to find patterns of RT for prostate cancer patients in Korea. Results: The number of patients with prostate cancer treated with definitive RT ranged from 1 to 72 per hospital in 2013. RT doses and target volumes increased according to risk groups but the range of radiation doses was wide (60 to 81.4 Gy) and the fraction size was diverse (1.8 to 5 Gy). Intensity-modulated radiation therapy was used for definitive treatment in 93.8% of hospitals. Hormonal therapy was integrated with radiation for intermediate (63.2%) and high risk patients (77.2%). Adjuvant RT after radical prostatectomy was performed in 46 hospitals (80.7%). Indications of adjuvant RT included positive resection margin, seminal vesicle invasion, and capsular invasion. The total dose for adjuvant RT ranged from 50 to 72 Gy in 24-39 fractions. Salvage RT was delivered with findings of consecutive elevations in prostate-specific antigen (PSA), PSA level over 0.2 ng/mL, or clinical recurrence. The total radiation doses ranged from 50 to 80 Gy with a range of 1.8 to 2.5 Gy per fraction for salvage RT. Conclusion: This nationwide patterns of care study suggests that variable radiation techniques and a diverse range of dose fractionation schemes are applied for prostate cancer treatment in Korea. Standard guidelines for RT in prostate cancer need to be developed.

• 대한골관절종양학회지
• /
• 제10권2호
• /
• pp.96-106
• /
• 2004

목적: 악성 골, 연부 조직 종양 환자에게 시행한 자가골 재이식술을 이용한 사지 구제술의 치료 결과를 분석하여 그 유용성을 알아보고자 하였다. 대상 및 방법: 1990년 2월부터 2003년 1월까지 악성 골, 연부 조직 종양으로 자가골 재이식술을 이용한 사지 구제술을 시행 받은 환자 중에서 최소 18개월 이상 장기 추시가 가능했던 29예를 대상으로 하였다. 남자가 18예, 여자가 11예로 환자의 평균 연령은 33세(범위, 10~65세)였고, 평균 추시 기간은 51.8개월(범위, 18~117개월)이었으며 Enneking의 분류에 따른 병기는 IIA가 10예, IIB가 19예였다. 자가골의 재처리 방법은 동결 처리법(deep freezing)이 6예, 고온-고압 처리법(autoclaving) 11예, 저온 처리법(pasteurization이) 7예였으며, 5예 에서는 고온-고압 처리법과 혈관 부착 비골 이식술을 병행하였다. 단순 방사선 검사를 통하여 골 유합을 평가하였고, 1993년에 국제 사지 보존 회의(International Symposium On Limb Salvage; ISOLS)에서 수정 보완한 방법을 이용하여 기능을 평가하였다. 결과: 골 유합 기간은 평균 7.2개월(범위, 3~15개월)로, 동결 처리법은 5.8개월(범위, 4~8개월), 고온-고압 처리법은 9.7개월(범위, 6~15개월), 저온 처리법은 5.9개월(범위, 4~8개월)이었고, 고온-고압 처리법과 혈관 부착 비골 이식술을 병행한 경우는 5개월(범위, 3~7개월)이었다. 기능 평가 백분율은 평균 76.8% (범위, 40~90%)로, 동결 처리법은 65.8% (범위, 40~85%), 고온-고압 처리법은 76.6%(범위, 40~90%), 저온 처리법은 81.6%(범위, 70~90%)였고, 고온-고압 처리법과 혈관 부착 비골 이식술을 병행한 경우는 83.4%(범위, 75~90%)였다. 6예에서 합병증이 발생하였는데 국소 재발, 폐 전이, 감염, 골절이 각각 1예였고, 절골부의 불유합이 2예였다. 결론: 자가골 재이식술을 이용한 사지 구제술은 악성 골, 연부 조직 종양의 유용한 치료 방법이며, 특히 고온-고압 처리법을 이용한 자가골 재이식술은 국소 재발을 방지할 수 있는 확실한 방법이었으며, 혈관 부착 비골 이식술을 병행하면 재처리된 자가골의 기계적 강도나 골유도 능력이 감소하는 단점을 보완할 수 있을 것으로 판단된다.

• Radiation Oncology Journal
• /
• 제36권3호
• /
• pp.192-199
• /
• 2018

Purpose: Use of radiotherapy combined with chemotherapy is increasing in hypopharyngeal cancer. However, many show residual tumor after radiotherapy. Timing for treatment evaluation and salvage therapy is essential. However, optimal timing for salvage surgery has not been suggested. In this study, we tried to evaluate optimal timing for salvage surgery. Methods and Materials: Patients who were diagnosed with hypopharyngeal squamous cell carcinoma between 2006 and 2015 were retrospectively analyzed. All patients received definitive radiotherapy with or without chemotherapy. Response of all treated patients were analyzed at 1, 3, and 6 months after radiotherapy. Any patients with progression before 6 months were excluded. Results: A total of 54 patients were analyzed. Complete remission (CR) rates at 1 month (CR₁), 3 months (CR₃) and 6 months (CR₆) were 66.7%, 81.5%, and 90.7%, respectively. Non-CR at 1 month (NCR₁), 3 months (NCR₃), and 6 months (NCR₆) showed poor locoregional recurrence-free survival rates (1-year rates of 63.7%, 66.7%, and 0.0%, respectively) compared to CR₁, CR₃, and CR₆ (1-year rates 94.3%, 88.0%, and 91.5%, respectively). Particularly significant differences were seen between CR₆ and NCR₆ (p < 0.001). Of 10 patients with NCR₃, 5 showed CR at 6 months (NCR₃/CR₆). There was no statistical difference in locoregional recurrence-free survival between CR₃ and NCR₃/CR₆ group (p = 0.990). Conclusion: Our data suggest half of patients who did not show CR at 3 months eventually achieved CR at 6 months. Waiting until 6 months after radiotherapy may be appropriate for avoiding additional salvage therapy.

• Clinics in Shoulder and Elbow
• /
• 제13권1호
• /
• pp.132-140
• /
• 2010

목적: 광범위 회전근 개 파열에 대한 수술적 치료는 매우 어려우며, 다양한 수술 방법이 알려져 있다. 여러 수술 방법 중 광범위 회전근 개 파열에서 적용될 수 있는 관절 성형술에 대해 고찰하고자 한다. 대상 및 방법: 광범위 회전근 개 파열에 대한 수술 방법 중 하나인 관절 성형술에 관한 문헌들을 조사하여 요약하고 정리하였다. 결과: 봉합이 불가능한 광범위 회전근 개 파열 환자에서 관절 성형술은 일차적 치료법 또는 구제술로 사용될 수 있으며, 반관절 성형술은 오구 견봉 궁이 건재할 경우 Neer의 제한적 기준을 목표로 삼는다면 만족스런 결과를 얻을 수 있다. 또한, 역형 견관절 전 성형술은 가성 마비를 동반한 고령의 환자에서 동통 완화와 능동적 거상을 회복할 수 있는 구제술이다. 결론: 치료가 어려운 광범위 회전근 개 파열 환자에서 적절한 관절 성형술의 선택은 견관절의 동통 완화와 기능적 관절 운동 범위 회복을 가능케 할 수 있을 것으로 사료된다.

• Radiation Oncology Journal
• /
• 제35권1호
• /
• pp.55-64
• /
• 2017

Purpose: The outcomes and toxicities of locoregionally recurrent non-small-cell lung cancer (NSCLC) patients treated with curative radiotherapy were evaluated in the modern era. Materials and Methods: Fifty-seven patients receiving radical radiotherapy for locoregionally recurrent NSCLC without distant metastasis after surgery from 2004 to 2014 were reviewed. Forty-two patients were treated with concurrent chemoradiotherapy (CCRT), and 15 patients with radiotherapy alone. The median radiation dose was 66 Gy (range, 45 to 70 Gy). Lung function change after radiotherapy was evaluated by comparing pulmonary function tests before and at 1, 6, and 12 months after radiotherapy. Results: Median follow-up was 53.6 months (range, 12.0 to 107.5 months) among the survivors. The median overall survival (OS) and progression-free survival (PFS) were 54.8 months (range, 3.0 to 116.9 months) and 12.2 months (range, 0.8 to 100.2 months), respectively. Multivariate analyses revealed that single locoregional recurrence focus and use of concurrent chemotherapy were significant prognostic factors for OS (p = 0.048 and p = 0.001, respectively) and PFS (p = 0.002 and p = 0.026, respectively). There was no significant change in predicted forced expiratory volume in one second after radiotherapy. Although diffusing lung capacity for carbon monoxide decreased significantly at 1 month after radiotherapy (p < 0.001), it recovered to pretreatment levels within 12 months. Acute grade 3 radiation pneumonitis and esophagitis were observed in 3 and 2 patients, respectively. There was no chronic complication observed in all patients. Conclusion: Salvage radiotherapy showed good survival outcomes without severe complications in postoperative locoregionally recurrent NSCLC patients. A single locoregional recurrent focus and the use of CCRT chemotherapy were associated with improved survival. CCRT should be considered as a salvage treatment in patients with good prognostic factors.

• Journal of Trauma and Injury
• /
• 제32권2호
• /
• pp.93-100
• /
• 2019

Purpose: Penetrating vascular trauma though less common poses a challenge to all Surgeons. This study was designed to analyse the profile, management modalities of vascular trauma and the outcomes thereof at a Trauma Care Centre in a Tertiary care setting in hostile environment in India. Methods: A prospective review of all patients with arterial and venous injuries being transferred to the Trauma Center at out Tertiary Care Center between June 2015 and May 2018 was done. Demographics, admission data, treatment, and complications were reviewed. Results: There were a total of 46 patients with 65 vascular injuries, 39 arterial injuries and 26 venous injuries. The age range was 21 to 47 years. Nineteen patients had both arterial and venous injuries. A total of 42 cases presented within 12 hours of injury and complete arterial transections were found in 33 cases (80.49%). There were three mortalities (6.52%) and three amputations (8.33%). The overall limb salvage rate was 91.67% with popliteal artery being the commonest injured artery. Poor prognosticators for limb salvage were increasing time to present to the trauma centre, hypovolemic shock, multi-organ trauma and associated venous injuries. Conclusions: Penetrating missile trauma leading to vascular injuries has not been widely reported. Attempting limb salvage even in cases with delayed presentation should be weighed with the threat to life before revascularisation and should preferably be done at a centre with vascular expertise. A team approach with vascular, orthopaedic, general surgeons, and critical care anaesthesiologists all aboard improve the outcomes manifold. Use of tourniquets and early fasciotomies have been emphasized as is the use of native veins as the bypass conduit. This is probably the largest study on penetrating Vascular trauma in anti-terrorism ops from the Indian subcontinent. It highlights the significance of prompt recognition and availability of vascular expertise in optimally managing cases of vascular trauma.

• Journal of Digestive Cancer Research
• /
• 제3권2호
• /
• pp.108-112
• /
• 2015

위암의 재발은 환자의 예후를 불량하게 하며, 재발성 위암의 치료 방법은 재발 양상에 따라서 달라질 수 있고, 국내외적으로 항암치료를 제외한 치료 방법에 대해 뚜렷한 지침이 정해져 있지는 않다. 저자들은 근치적 위절제술 시행 후 림프절 전이가 발생한 진행성 위암 환자에서 고식적 항암화학치료와 구제 방사선요법을 시행한 뒤 완전 관해에 도달한 증례를 경험하였기에 문헌 고찰과 함께 보고하는 바이다.

• 대한족부족관절학회지
• /
• 제18권2호
• /
• pp.76-79
• /
• 2014

In treatment of failure in ankle joint replacement therapy, talar avascular necrosis with massive bone defect, talus fracture with severe comminution and bone defect and ankle dislocation, treatment of large bone defects is considerably important for ankle joint stability and union, therefore, the choice of treatment for large bone defects is use of femoral head or iliac crest bone graft and rigid internal fixation. Because first generation total ankle arthroplasty performed for the first time using a cemented fixation technique requires a large amount of bone resection during re-surgery and there is some possibility of a larger bone defect after removal of implants, in cases where prosthesis for the defect is needed, performance of palliative femoral head or iliac crest bone graft and rigid internal fixation can be difficult. We report on a case of a 48-year-old woman who had experienced ankle pain for 25 years since undergoing total ankle arthroplasty. Because the patient had little ankle motion and rigid soft tissue despite a large bone defect caused by aseptic loosening, a good outcome was obtained only for the femoral cancellous bone graft using allo femoral head without internal fixation.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권6호
• /
• pp.2391-2395
• /
• 2015

Objective: The aim of this retrospective study was to evaluate the feasibility and efficacy of response to continuous-infusion ifosfamide and doxorubicin combination as second-line chemotherapy for patients with recurrent or refractory osteosarcoma. Materials and Methods: Eighteen recurrent or refractory osteosarcoma patients who were treated with continuous-infusion ifosfamide and doxorubicin combination between May 1999 and April 2011 were included in the analysis. Ifosfamide at $12g/m^2$ was administered by intravenous continuous infusion over 3 days, and doxorubicin $60mg/m^2$ was administered as an intravenous bolus injection on day 1. The combination therapy was repeated every 3 weeks. Treatment was continued until evidence of disease progression or unacceptable toxicity. Results: The patients (ages 7-53 years) received a total of 42 cycles of chemotherapy (median: 2 courses; range: 2-5 courses). The overall response rate was 0% and the disease control rate was 22.3%, with four patients having stable disease. The median time to progression and overall survival time were 2 months (range: 2-5 months) and 9 months (range: 3-29 months), respectively. Major severe toxicities were leucopenia 7 (38.9%), nausea and vomiting 3 (16.7%) and alopecia 9 (50%). There were no treatment-related deaths. Conclusions: In our experience, continuous-infusion ifosfamide and doxorubicin combination therapy at this dosage and schedule was found to be well tolerated and moderate effective, which could be considered as salvage therapy for patients with recurrent or refractory osteosarcoma. Further assessment is necessary to confirm the safety and efficacy of this treatment.